Clinical Trial Update: Long-Term Study (AtDvance) to Evaluate GSK1070806 in Atopic Dermatitis. [Phase 2]

View source ↗

Summary

A Phase 2 long-term study (AtDvance) evaluating GSK1070806 for atopic dermatitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• GSK1070806

Snippet

Sponsor: GlaxoSmithKline | Conditions: Dermatitis, Atopic | Phase 2 | Status: TERMINATED